Review



control shrna plasmid shctr  (Addgene inc)


Bioz Verified Symbol Addgene inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Addgene inc control shrna plasmid shctr
    A Barplot showing the expression of SPINK2 measured by qPCR in a panel of AML cell lines. n = 6 for each cell line. B Bowtie plot representing SPINK2 mRNA quantification by q-PCR following SPINK2 <t>shRNA</t> silencing and normalized using GAPDH ( n = 6). C Lineplot displaying cell viability upon SPINK2 knock-down determined by counting cells every 24 h for four consecutive days post shRNA induction. The results are indicative of 3 independent experiments ( n = 6). D Two-dimensional flow cytometric dot plot showing BrdU incorporation 72 hours post doxycycline induction. The three gates indicate the G0/G1, S and G2/M phases of the cell cycle. The barplot on the righthand side represent an average of three independent experiments ( n = 6). E Bowtie plot showing the percentages of Annexin V + apoptotic/necrotic cells. F Representative two-dimensional flow cytometric contour plots showing the expression levels of CD14, CD64, CD35 and CD300E in FUJIOKA cells that have undergone SPINK2 silencing 96 hours post doxycycline induction ( n = 6). The statistical analysis reported in this figure have been performed using student’s t test (*** p < 0.001, * p < 0.05).
    Control Shrna Plasmid Shctr, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 33 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/control shrna plasmid shctr/product/Addgene inc
    Average 93 stars, based on 33 article reviews
    control shrna plasmid shctr - by Bioz Stars, 2026-05
    93/100 stars

    Images

    1) Product Images from "SPINK2 silencing suppresses leukemic proliferation and restores myeloid commitment via MECOM downregulation in acute myeloid leukaemia"

    Article Title: SPINK2 silencing suppresses leukemic proliferation and restores myeloid commitment via MECOM downregulation in acute myeloid leukaemia

    Journal: Cell Death Discovery

    doi: 10.1038/s41420-026-02988-1

    A Barplot showing the expression of SPINK2 measured by qPCR in a panel of AML cell lines. n = 6 for each cell line. B Bowtie plot representing SPINK2 mRNA quantification by q-PCR following SPINK2 shRNA silencing and normalized using GAPDH ( n = 6). C Lineplot displaying cell viability upon SPINK2 knock-down determined by counting cells every 24 h for four consecutive days post shRNA induction. The results are indicative of 3 independent experiments ( n = 6). D Two-dimensional flow cytometric dot plot showing BrdU incorporation 72 hours post doxycycline induction. The three gates indicate the G0/G1, S and G2/M phases of the cell cycle. The barplot on the righthand side represent an average of three independent experiments ( n = 6). E Bowtie plot showing the percentages of Annexin V + apoptotic/necrotic cells. F Representative two-dimensional flow cytometric contour plots showing the expression levels of CD14, CD64, CD35 and CD300E in FUJIOKA cells that have undergone SPINK2 silencing 96 hours post doxycycline induction ( n = 6). The statistical analysis reported in this figure have been performed using student’s t test (*** p < 0.001, * p < 0.05).
    Figure Legend Snippet: A Barplot showing the expression of SPINK2 measured by qPCR in a panel of AML cell lines. n = 6 for each cell line. B Bowtie plot representing SPINK2 mRNA quantification by q-PCR following SPINK2 shRNA silencing and normalized using GAPDH ( n = 6). C Lineplot displaying cell viability upon SPINK2 knock-down determined by counting cells every 24 h for four consecutive days post shRNA induction. The results are indicative of 3 independent experiments ( n = 6). D Two-dimensional flow cytometric dot plot showing BrdU incorporation 72 hours post doxycycline induction. The three gates indicate the G0/G1, S and G2/M phases of the cell cycle. The barplot on the righthand side represent an average of three independent experiments ( n = 6). E Bowtie plot showing the percentages of Annexin V + apoptotic/necrotic cells. F Representative two-dimensional flow cytometric contour plots showing the expression levels of CD14, CD64, CD35 and CD300E in FUJIOKA cells that have undergone SPINK2 silencing 96 hours post doxycycline induction ( n = 6). The statistical analysis reported in this figure have been performed using student’s t test (*** p < 0.001, * p < 0.05).

    Techniques Used: Expressing, shRNA, Knockdown, BrdU Incorporation Assay



    Similar Products

    93
    Addgene inc control shrna plasmid shctr
    A Barplot showing the expression of SPINK2 measured by qPCR in a panel of AML cell lines. n = 6 for each cell line. B Bowtie plot representing SPINK2 mRNA quantification by q-PCR following SPINK2 <t>shRNA</t> silencing and normalized using GAPDH ( n = 6). C Lineplot displaying cell viability upon SPINK2 knock-down determined by counting cells every 24 h for four consecutive days post shRNA induction. The results are indicative of 3 independent experiments ( n = 6). D Two-dimensional flow cytometric dot plot showing BrdU incorporation 72 hours post doxycycline induction. The three gates indicate the G0/G1, S and G2/M phases of the cell cycle. The barplot on the righthand side represent an average of three independent experiments ( n = 6). E Bowtie plot showing the percentages of Annexin V + apoptotic/necrotic cells. F Representative two-dimensional flow cytometric contour plots showing the expression levels of CD14, CD64, CD35 and CD300E in FUJIOKA cells that have undergone SPINK2 silencing 96 hours post doxycycline induction ( n = 6). The statistical analysis reported in this figure have been performed using student’s t test (*** p < 0.001, * p < 0.05).
    Control Shrna Plasmid Shctr, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/control shrna plasmid shctr/product/Addgene inc
    Average 93 stars, based on 1 article reviews
    control shrna plasmid shctr - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    90
    Millipore non-mammalian shrna control (shctr, shc002)
    A Barplot showing the expression of SPINK2 measured by qPCR in a panel of AML cell lines. n = 6 for each cell line. B Bowtie plot representing SPINK2 mRNA quantification by q-PCR following SPINK2 <t>shRNA</t> silencing and normalized using GAPDH ( n = 6). C Lineplot displaying cell viability upon SPINK2 knock-down determined by counting cells every 24 h for four consecutive days post shRNA induction. The results are indicative of 3 independent experiments ( n = 6). D Two-dimensional flow cytometric dot plot showing BrdU incorporation 72 hours post doxycycline induction. The three gates indicate the G0/G1, S and G2/M phases of the cell cycle. The barplot on the righthand side represent an average of three independent experiments ( n = 6). E Bowtie plot showing the percentages of Annexin V + apoptotic/necrotic cells. F Representative two-dimensional flow cytometric contour plots showing the expression levels of CD14, CD64, CD35 and CD300E in FUJIOKA cells that have undergone SPINK2 silencing 96 hours post doxycycline induction ( n = 6). The statistical analysis reported in this figure have been performed using student’s t test (*** p < 0.001, * p < 0.05).
    Non Mammalian Shrna Control (Shctr, Shc002), supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/non-mammalian shrna control (shctr, shc002)/product/Millipore
    Average 90 stars, based on 1 article reviews
    non-mammalian shrna control (shctr, shc002) - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    Addgene inc non-targeting control shrna (shctr)
    a Areaproportional Venn diagram of gene sets enriched with EIF4EBP1 expression in cohort 1 (A) and 2 (B) as well as with chr8 gain in cohort 2 (C) as determined by fGSEA. Exemplary gene sets representing a proliferation-associated enrichment signature in the overlap between A, B, and C were shown with respective normalized enrichment scores (NES) and significance levels. b fGSEA enrichment plots of exemplary gene sets given in (a). c Relative viable cell count of A-673, SK-N-MC, and TC-71 cells containing <t>either</t> <t>Dox-inducible</t> specific <t>shRNA</t> constructs directed against EIF4EBP1 (sh4E-BP1_1 or sh4E-BP1_2) or a non-targeting shControl (shCtr). Cells were grown either with or without Dox for 96h. Horizontal bars represent means, and whiskers represent the SEM, n ≥ 4 biologically independent experiments. d Sphere formation in A-673, SK-N-MC, and TC-71 cells containing shRNA constructs directed against EIF4EBP1 (sh4E-BP1_1 or sh4E-BP1_2) or a non-targeting shControl (shCtr) treated with or without Dox for 8–14 d. Horizontal bars represent means, and whiskers represent the SEM, n ≥ 3 biologically independent experiments. Two-tailed unpaired t-test with Welch’s correction. Representative images of spheres are shown on the right. e Relative colony number of A-673 and SK-N-MC cells containing either Dox-inducible specific shRNA constructs directed against EIF4EBP1 (sh4E-BP1_1 or sh4E-BP1_2) or a nontargeting shControl (shCtr). Cells were grown either with or without Dox for 8–14 d. Horizontal bars represent means, and whiskers the SEM, n ≥ 4 biologically independent experiments. Representative images of colony formation are shown on the right. f Kaplan-Meier analysis of event-free survival of NSG mice xenografted with A-673 cells containing either Dox-inducible specific shRNA constructs directed against EIF4EBP1 (sh4E-BP1_1 or sh4E-BP1_2) or a non-targeting shControl (shCtr). Once tumors were palpable, mice were randomized and treated with either vehicle (–) or Dox (+), n ≥ 5 animals per condition. An ‘event’ is recorded when tumors reached a size maximum of 15 mm in one dimension. P -values determined via Mantel-Haenszel test. g Quantification of mitoses in HE-stained slides of xenografts described in (f). Five high-power fields (HPF) were counted per sample. Horizontal bars represent means, and whiskers represent the SEM, n ≥ 4 samples per condition. *** P < 0.001, ** P < 0.01, * P < 0.05, ns = not significant; P -values determined via two-tailed Mann-Whitney test if not otherwise specified.
    Non Targeting Control Shrna (Shctr), supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/non-targeting control shrna (shctr)/product/Addgene inc
    Average 90 stars, based on 1 article reviews
    non-targeting control shrna (shctr) - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    Millipore nonsilencing shctr (mission control shrna plasmid dna
    a Areaproportional Venn diagram of gene sets enriched with EIF4EBP1 expression in cohort 1 (A) and 2 (B) as well as with chr8 gain in cohort 2 (C) as determined by fGSEA. Exemplary gene sets representing a proliferation-associated enrichment signature in the overlap between A, B, and C were shown with respective normalized enrichment scores (NES) and significance levels. b fGSEA enrichment plots of exemplary gene sets given in (a). c Relative viable cell count of A-673, SK-N-MC, and TC-71 cells containing <t>either</t> <t>Dox-inducible</t> specific <t>shRNA</t> constructs directed against EIF4EBP1 (sh4E-BP1_1 or sh4E-BP1_2) or a non-targeting shControl (shCtr). Cells were grown either with or without Dox for 96h. Horizontal bars represent means, and whiskers represent the SEM, n ≥ 4 biologically independent experiments. d Sphere formation in A-673, SK-N-MC, and TC-71 cells containing shRNA constructs directed against EIF4EBP1 (sh4E-BP1_1 or sh4E-BP1_2) or a non-targeting shControl (shCtr) treated with or without Dox for 8–14 d. Horizontal bars represent means, and whiskers represent the SEM, n ≥ 3 biologically independent experiments. Two-tailed unpaired t-test with Welch’s correction. Representative images of spheres are shown on the right. e Relative colony number of A-673 and SK-N-MC cells containing either Dox-inducible specific shRNA constructs directed against EIF4EBP1 (sh4E-BP1_1 or sh4E-BP1_2) or a nontargeting shControl (shCtr). Cells were grown either with or without Dox for 8–14 d. Horizontal bars represent means, and whiskers the SEM, n ≥ 4 biologically independent experiments. Representative images of colony formation are shown on the right. f Kaplan-Meier analysis of event-free survival of NSG mice xenografted with A-673 cells containing either Dox-inducible specific shRNA constructs directed against EIF4EBP1 (sh4E-BP1_1 or sh4E-BP1_2) or a non-targeting shControl (shCtr). Once tumors were palpable, mice were randomized and treated with either vehicle (–) or Dox (+), n ≥ 5 animals per condition. An ‘event’ is recorded when tumors reached a size maximum of 15 mm in one dimension. P -values determined via Mantel-Haenszel test. g Quantification of mitoses in HE-stained slides of xenografts described in (f). Five high-power fields (HPF) were counted per sample. Horizontal bars represent means, and whiskers represent the SEM, n ≥ 4 samples per condition. *** P < 0.001, ** P < 0.01, * P < 0.05, ns = not significant; P -values determined via two-tailed Mann-Whitney test if not otherwise specified.
    Nonsilencing Shctr (Mission Control Shrna Plasmid Dna, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nonsilencing shctr (mission control shrna plasmid dna/product/Millipore
    Average 90 stars, based on 1 article reviews
    nonsilencing shctr (mission control shrna plasmid dna - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    96
    Santa Cruz Biotechnology hairpin rnas shrna sequence sequence shctr
    Metabolic changes in H295R cells related to ERRα expression levels. The metabolic profiles of H295R wild type (WT), <t>shCTR,</t> shERRα−/− and ERRα+/+ cells were assessed by Seahorse XFe96 Analyzer. ( a , b ) ATP Rate Assay was evaluated as indicated in “Materials and Methods”. Graphs represent the mean ± SD of three independent experiments of Total ATP Production Rate (pmol/min) ( a ) and ATP production (%) ( b ) deriving from glycolysis and oxidative phosphorylation after the sequential addition of specific inhibitors; (* p < 0.05 vs. WT). ( c – e ) Mitochondrial Stress Analysis was performed as indicated in “Materials and Methods”. Graphs represent the mean ± SD of three independent experiments of real-time oxygen consumption (OCR) rate (pmol/min/cells); (* p < 0.05 vs. shCTR). Mitochondrial Respiration ( c ), Basal Respiration ( d ), Maximal Respiration ( e ) were measured from OCR after the addition of specific inhibitors. ( f – h ) Glycolytic Stress Analysis was performed as indicated in “Materials and Methods”. Graph represents the mean ± SD of three independent experiments of Real-time extracellular acidification (ECAR) rate (mpH/min/cells); (* p < 0.05 vs. shCTR). Glycolitic function ( f ), Glycolysis ( g ) and Glycolytic Capacity ( h ) were measured from ECAR after the addition of specific inhibitors.
    Hairpin Rnas Shrna Sequence Sequence Shctr, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hairpin rnas shrna sequence sequence shctr/product/Santa Cruz Biotechnology
    Average 96 stars, based on 1 article reviews
    hairpin rnas shrna sequence sequence shctr - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    96
    Addgene inc control shrna shctr
    Metabolic changes in H295R cells related to ERRα expression levels. The metabolic profiles of H295R wild type (WT), <t>shCTR,</t> shERRα−/− and ERRα+/+ cells were assessed by Seahorse XFe96 Analyzer. ( a , b ) ATP Rate Assay was evaluated as indicated in “Materials and Methods”. Graphs represent the mean ± SD of three independent experiments of Total ATP Production Rate (pmol/min) ( a ) and ATP production (%) ( b ) deriving from glycolysis and oxidative phosphorylation after the sequential addition of specific inhibitors; (* p < 0.05 vs. WT). ( c – e ) Mitochondrial Stress Analysis was performed as indicated in “Materials and Methods”. Graphs represent the mean ± SD of three independent experiments of real-time oxygen consumption (OCR) rate (pmol/min/cells); (* p < 0.05 vs. shCTR). Mitochondrial Respiration ( c ), Basal Respiration ( d ), Maximal Respiration ( e ) were measured from OCR after the addition of specific inhibitors. ( f – h ) Glycolytic Stress Analysis was performed as indicated in “Materials and Methods”. Graph represents the mean ± SD of three independent experiments of Real-time extracellular acidification (ECAR) rate (mpH/min/cells); (* p < 0.05 vs. shCTR). Glycolitic function ( f ), Glycolysis ( g ) and Glycolytic Capacity ( h ) were measured from ECAR after the addition of specific inhibitors.
    Control Shrna Shctr, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/control shrna shctr/product/Addgene inc
    Average 96 stars, based on 1 article reviews
    control shrna shctr - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    90
    Genechem lentivirus-control-shrna lv-shctr
    Metabolic changes in H295R cells related to ERRα expression levels. The metabolic profiles of H295R wild type (WT), <t>shCTR,</t> shERRα−/− and ERRα+/+ cells were assessed by Seahorse XFe96 Analyzer. ( a , b ) ATP Rate Assay was evaluated as indicated in “Materials and Methods”. Graphs represent the mean ± SD of three independent experiments of Total ATP Production Rate (pmol/min) ( a ) and ATP production (%) ( b ) deriving from glycolysis and oxidative phosphorylation after the sequential addition of specific inhibitors; (* p < 0.05 vs. WT). ( c – e ) Mitochondrial Stress Analysis was performed as indicated in “Materials and Methods”. Graphs represent the mean ± SD of three independent experiments of real-time oxygen consumption (OCR) rate (pmol/min/cells); (* p < 0.05 vs. shCTR). Mitochondrial Respiration ( c ), Basal Respiration ( d ), Maximal Respiration ( e ) were measured from OCR after the addition of specific inhibitors. ( f – h ) Glycolytic Stress Analysis was performed as indicated in “Materials and Methods”. Graph represents the mean ± SD of three independent experiments of Real-time extracellular acidification (ECAR) rate (mpH/min/cells); (* p < 0.05 vs. shCTR). Glycolitic function ( f ), Glycolysis ( g ) and Glycolytic Capacity ( h ) were measured from ECAR after the addition of specific inhibitors.
    Lentivirus Control Shrna Lv Shctr, supplied by Genechem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/lentivirus-control-shrna lv-shctr/product/Genechem
    Average 90 stars, based on 1 article reviews
    lentivirus-control-shrna lv-shctr - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    96
    Santa Cruz Biotechnology non target control shrna shctr
    PHGDH knockdown potentiates bortezomib and proteasome-resistant cell lines are sensitive to PHGDH inhibition. a The knockdown of PHGDH using <t>shRNA</t> was confirmed via WB. b CTG was used to highlight the dependence of the shPHGDH cells on extracellular serine. The sensitivity to drugs was tested by CTG. c , d INA6 KD cells were treated overnight with carfilzomib and bortezomib, respectively. e , f INA6-res and AMO1-res cell lines, respectively, were treated with the indicated doses of NCT-503 overnight. All the presented graphs and calculated IC50s represent three independent experiments with minimum two replicates. Error bars are ± SEM and * P ≤ 0.05 , ** P ≤ 0.01, *** P ≤ 0.001
    Non Target Control Shrna Shctr, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/non target control shrna shctr/product/Santa Cruz Biotechnology
    Average 96 stars, based on 1 article reviews
    non target control shrna shctr - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    Image Search Results


    A Barplot showing the expression of SPINK2 measured by qPCR in a panel of AML cell lines. n = 6 for each cell line. B Bowtie plot representing SPINK2 mRNA quantification by q-PCR following SPINK2 shRNA silencing and normalized using GAPDH ( n = 6). C Lineplot displaying cell viability upon SPINK2 knock-down determined by counting cells every 24 h for four consecutive days post shRNA induction. The results are indicative of 3 independent experiments ( n = 6). D Two-dimensional flow cytometric dot plot showing BrdU incorporation 72 hours post doxycycline induction. The three gates indicate the G0/G1, S and G2/M phases of the cell cycle. The barplot on the righthand side represent an average of three independent experiments ( n = 6). E Bowtie plot showing the percentages of Annexin V + apoptotic/necrotic cells. F Representative two-dimensional flow cytometric contour plots showing the expression levels of CD14, CD64, CD35 and CD300E in FUJIOKA cells that have undergone SPINK2 silencing 96 hours post doxycycline induction ( n = 6). The statistical analysis reported in this figure have been performed using student’s t test (*** p < 0.001, * p < 0.05).

    Journal: Cell Death Discovery

    Article Title: SPINK2 silencing suppresses leukemic proliferation and restores myeloid commitment via MECOM downregulation in acute myeloid leukaemia

    doi: 10.1038/s41420-026-02988-1

    Figure Lengend Snippet: A Barplot showing the expression of SPINK2 measured by qPCR in a panel of AML cell lines. n = 6 for each cell line. B Bowtie plot representing SPINK2 mRNA quantification by q-PCR following SPINK2 shRNA silencing and normalized using GAPDH ( n = 6). C Lineplot displaying cell viability upon SPINK2 knock-down determined by counting cells every 24 h for four consecutive days post shRNA induction. The results are indicative of 3 independent experiments ( n = 6). D Two-dimensional flow cytometric dot plot showing BrdU incorporation 72 hours post doxycycline induction. The three gates indicate the G0/G1, S and G2/M phases of the cell cycle. The barplot on the righthand side represent an average of three independent experiments ( n = 6). E Bowtie plot showing the percentages of Annexin V + apoptotic/necrotic cells. F Representative two-dimensional flow cytometric contour plots showing the expression levels of CD14, CD64, CD35 and CD300E in FUJIOKA cells that have undergone SPINK2 silencing 96 hours post doxycycline induction ( n = 6). The statistical analysis reported in this figure have been performed using student’s t test (*** p < 0.001, * p < 0.05).

    Article Snippet: A scrambled control shRNA plasmid (shCtr), Tet-pLKO-puro-Scrambled (Addgene plasmid #47541), was used as a non-targeting control [ ].

    Techniques: Expressing, shRNA, Knockdown, BrdU Incorporation Assay

    a Areaproportional Venn diagram of gene sets enriched with EIF4EBP1 expression in cohort 1 (A) and 2 (B) as well as with chr8 gain in cohort 2 (C) as determined by fGSEA. Exemplary gene sets representing a proliferation-associated enrichment signature in the overlap between A, B, and C were shown with respective normalized enrichment scores (NES) and significance levels. b fGSEA enrichment plots of exemplary gene sets given in (a). c Relative viable cell count of A-673, SK-N-MC, and TC-71 cells containing either Dox-inducible specific shRNA constructs directed against EIF4EBP1 (sh4E-BP1_1 or sh4E-BP1_2) or a non-targeting shControl (shCtr). Cells were grown either with or without Dox for 96h. Horizontal bars represent means, and whiskers represent the SEM, n ≥ 4 biologically independent experiments. d Sphere formation in A-673, SK-N-MC, and TC-71 cells containing shRNA constructs directed against EIF4EBP1 (sh4E-BP1_1 or sh4E-BP1_2) or a non-targeting shControl (shCtr) treated with or without Dox for 8–14 d. Horizontal bars represent means, and whiskers represent the SEM, n ≥ 3 biologically independent experiments. Two-tailed unpaired t-test with Welch’s correction. Representative images of spheres are shown on the right. e Relative colony number of A-673 and SK-N-MC cells containing either Dox-inducible specific shRNA constructs directed against EIF4EBP1 (sh4E-BP1_1 or sh4E-BP1_2) or a nontargeting shControl (shCtr). Cells were grown either with or without Dox for 8–14 d. Horizontal bars represent means, and whiskers the SEM, n ≥ 4 biologically independent experiments. Representative images of colony formation are shown on the right. f Kaplan-Meier analysis of event-free survival of NSG mice xenografted with A-673 cells containing either Dox-inducible specific shRNA constructs directed against EIF4EBP1 (sh4E-BP1_1 or sh4E-BP1_2) or a non-targeting shControl (shCtr). Once tumors were palpable, mice were randomized and treated with either vehicle (–) or Dox (+), n ≥ 5 animals per condition. An ‘event’ is recorded when tumors reached a size maximum of 15 mm in one dimension. P -values determined via Mantel-Haenszel test. g Quantification of mitoses in HE-stained slides of xenografts described in (f). Five high-power fields (HPF) were counted per sample. Horizontal bars represent means, and whiskers represent the SEM, n ≥ 4 samples per condition. *** P < 0.001, ** P < 0.01, * P < 0.05, ns = not significant; P -values determined via two-tailed Mann-Whitney test if not otherwise specified.

    Journal: bioRxiv

    Article Title: Chromosome 8 gain drives poor patient outcome via expression of 4E-BP1 in Ewing sarcoma

    doi: 10.1101/2022.12.11.519935

    Figure Lengend Snippet: a Areaproportional Venn diagram of gene sets enriched with EIF4EBP1 expression in cohort 1 (A) and 2 (B) as well as with chr8 gain in cohort 2 (C) as determined by fGSEA. Exemplary gene sets representing a proliferation-associated enrichment signature in the overlap between A, B, and C were shown with respective normalized enrichment scores (NES) and significance levels. b fGSEA enrichment plots of exemplary gene sets given in (a). c Relative viable cell count of A-673, SK-N-MC, and TC-71 cells containing either Dox-inducible specific shRNA constructs directed against EIF4EBP1 (sh4E-BP1_1 or sh4E-BP1_2) or a non-targeting shControl (shCtr). Cells were grown either with or without Dox for 96h. Horizontal bars represent means, and whiskers represent the SEM, n ≥ 4 biologically independent experiments. d Sphere formation in A-673, SK-N-MC, and TC-71 cells containing shRNA constructs directed against EIF4EBP1 (sh4E-BP1_1 or sh4E-BP1_2) or a non-targeting shControl (shCtr) treated with or without Dox for 8–14 d. Horizontal bars represent means, and whiskers represent the SEM, n ≥ 3 biologically independent experiments. Two-tailed unpaired t-test with Welch’s correction. Representative images of spheres are shown on the right. e Relative colony number of A-673 and SK-N-MC cells containing either Dox-inducible specific shRNA constructs directed against EIF4EBP1 (sh4E-BP1_1 or sh4E-BP1_2) or a nontargeting shControl (shCtr). Cells were grown either with or without Dox for 8–14 d. Horizontal bars represent means, and whiskers the SEM, n ≥ 4 biologically independent experiments. Representative images of colony formation are shown on the right. f Kaplan-Meier analysis of event-free survival of NSG mice xenografted with A-673 cells containing either Dox-inducible specific shRNA constructs directed against EIF4EBP1 (sh4E-BP1_1 or sh4E-BP1_2) or a non-targeting shControl (shCtr). Once tumors were palpable, mice were randomized and treated with either vehicle (–) or Dox (+), n ≥ 5 animals per condition. An ‘event’ is recorded when tumors reached a size maximum of 15 mm in one dimension. P -values determined via Mantel-Haenszel test. g Quantification of mitoses in HE-stained slides of xenografts described in (f). Five high-power fields (HPF) were counted per sample. Horizontal bars represent means, and whiskers represent the SEM, n ≥ 4 samples per condition. *** P < 0.001, ** P < 0.01, * P < 0.05, ns = not significant; P -values determined via two-tailed Mann-Whitney test if not otherwise specified.

    Article Snippet: Human EwS cell lines A-673, SK-N-MC, and TC-71 were transduced with lentiviral Tet-pLKO-puro all-in-one vector system (plasmid #21915, Addgene) containing a puromycin-resistance cassette, and a tet-responsive element for Dox-inducible expression of shRNAs against EIF4EBP1 (sh4E-BP1_1 or sh4E-BP1_2) or a non-targeting control shRNA (shCtr).

    Techniques: Expressing, Cell Counting, shRNA, Construct, Two Tailed Test, Staining, MANN-WHITNEY

    a Relative EIF4EBP1 expression in 21 wild-type EwS cell lines as determined by qRT-PCR. b Relative EIF4EBP1 expression as assessed by qRT-PCR in A-673, SK-N-MC, and TC-71 cells containing either Dox-inducible specific shRNA constructs directed against EIF4EBP1 (sh4E-BP1_1 or sh4E-BP1_2) or a non-targeting shControl (shCtr). Cells were grown either with or without Dox for 96h. Horizontal bars represent means, and whiskers represent the SEM, n ≥ 3 biologically independent experiments. c Relative 4E-BP1 expression as assessed by quantified western blotting in A-673, SK-N-MC, and TC-71 cells containing either Dox-inducible specific shRNA constructs directed against EIF4EBP1 (sh4E-BP1_1 or sh4E-BP1_2) or a non-targeting shControl (shCtr). Cells were grown either with or without Dox for 96h. P -values determined via one-tailed Mantel-Haenszel test. d Representative western blots as described in (b) are shown. ß-actin served as a loading control. e Relative number of dead cells as assessed by Trypan blue exclusion in A-673, SK-N-MC, and TC-71 cells containing either Dox-inducible specific shRNA constructs directed against EIF4EBP1 (sh4E-BP1_1 or sh4E-BP1_2) or a non-targeting shControl (shCtr). Cells were grown either with or without Dox for 96h. Horizontal bars represent means, and whiskers represent the SEM, n ≥ 4 biologically independent experiments. f Kaplan-Meier analysis of event-free survival of NSG mice xenografted with TC-71 cells containing Dox-inducible specific shRNA constructs directed against EIF4EBP1 (sh4E-BP1_1 or sh4E-BP1_2). Once tumors were palpable, mice were randomized and treated with either vehicle (–) or Dox (+), n =8 animals per condition. An ‘event’ is recorded when tumors reached a size maximum of 15 mm in one dimension. P -values determined via Mantel-Haenszel test. g Quantification of mitoses in HE-stained slides of xenografts described in (f). Five high-power fields (HPF) were counted per sample. Horizontal bars represent means, and whiskers represent the SEM, n ≥ 7 samples per condition. h Quantification of necrotic area on HE-stained slides of A-673 xenografts described in (f). Five high-power fields (HPF) were analyzed per sample. Horizontal bars represent means, and whiskers represent the SEM, n ≥ 5 samples per condition. i Quantification of necrotic area on HE-stained slides of TC-71 xenografts described in (f). Five high-power fields (HPF) were analyzed per sample. Horizontal bars represent means, and whiskers represent the SEM, n ≥ 7 samples per condition. j Kaplan-Meier analysis of event-free survival of NSG mice orthotopically xenografted into the proximal tibia with TC-71 containing a Dox-inducible specific shRNA construct directed against EIF4EBP1 (sh4E-BP1_2). One day after injection of the cells, mice were randomized and treated with either vehicle (−) or Dox (+), n =5 animals per condition. An ‘event’ is recorded when the mice exhibited signs of limping at the injected leg. P -values determined via Mantel-Haenszel test. *** P < 0.001, ** P < 0.01, * P < 0.05, ns = not significant; P values determined via two-tailed Mann-Whitney test if not otherwise specified.

    Journal: bioRxiv

    Article Title: Chromosome 8 gain drives poor patient outcome via expression of 4E-BP1 in Ewing sarcoma

    doi: 10.1101/2022.12.11.519935

    Figure Lengend Snippet: a Relative EIF4EBP1 expression in 21 wild-type EwS cell lines as determined by qRT-PCR. b Relative EIF4EBP1 expression as assessed by qRT-PCR in A-673, SK-N-MC, and TC-71 cells containing either Dox-inducible specific shRNA constructs directed against EIF4EBP1 (sh4E-BP1_1 or sh4E-BP1_2) or a non-targeting shControl (shCtr). Cells were grown either with or without Dox for 96h. Horizontal bars represent means, and whiskers represent the SEM, n ≥ 3 biologically independent experiments. c Relative 4E-BP1 expression as assessed by quantified western blotting in A-673, SK-N-MC, and TC-71 cells containing either Dox-inducible specific shRNA constructs directed against EIF4EBP1 (sh4E-BP1_1 or sh4E-BP1_2) or a non-targeting shControl (shCtr). Cells were grown either with or without Dox for 96h. P -values determined via one-tailed Mantel-Haenszel test. d Representative western blots as described in (b) are shown. ß-actin served as a loading control. e Relative number of dead cells as assessed by Trypan blue exclusion in A-673, SK-N-MC, and TC-71 cells containing either Dox-inducible specific shRNA constructs directed against EIF4EBP1 (sh4E-BP1_1 or sh4E-BP1_2) or a non-targeting shControl (shCtr). Cells were grown either with or without Dox for 96h. Horizontal bars represent means, and whiskers represent the SEM, n ≥ 4 biologically independent experiments. f Kaplan-Meier analysis of event-free survival of NSG mice xenografted with TC-71 cells containing Dox-inducible specific shRNA constructs directed against EIF4EBP1 (sh4E-BP1_1 or sh4E-BP1_2). Once tumors were palpable, mice were randomized and treated with either vehicle (–) or Dox (+), n =8 animals per condition. An ‘event’ is recorded when tumors reached a size maximum of 15 mm in one dimension. P -values determined via Mantel-Haenszel test. g Quantification of mitoses in HE-stained slides of xenografts described in (f). Five high-power fields (HPF) were counted per sample. Horizontal bars represent means, and whiskers represent the SEM, n ≥ 7 samples per condition. h Quantification of necrotic area on HE-stained slides of A-673 xenografts described in (f). Five high-power fields (HPF) were analyzed per sample. Horizontal bars represent means, and whiskers represent the SEM, n ≥ 5 samples per condition. i Quantification of necrotic area on HE-stained slides of TC-71 xenografts described in (f). Five high-power fields (HPF) were analyzed per sample. Horizontal bars represent means, and whiskers represent the SEM, n ≥ 7 samples per condition. j Kaplan-Meier analysis of event-free survival of NSG mice orthotopically xenografted into the proximal tibia with TC-71 containing a Dox-inducible specific shRNA construct directed against EIF4EBP1 (sh4E-BP1_2). One day after injection of the cells, mice were randomized and treated with either vehicle (−) or Dox (+), n =5 animals per condition. An ‘event’ is recorded when the mice exhibited signs of limping at the injected leg. P -values determined via Mantel-Haenszel test. *** P < 0.001, ** P < 0.01, * P < 0.05, ns = not significant; P values determined via two-tailed Mann-Whitney test if not otherwise specified.

    Article Snippet: Human EwS cell lines A-673, SK-N-MC, and TC-71 were transduced with lentiviral Tet-pLKO-puro all-in-one vector system (plasmid #21915, Addgene) containing a puromycin-resistance cassette, and a tet-responsive element for Dox-inducible expression of shRNAs against EIF4EBP1 (sh4E-BP1_1 or sh4E-BP1_2) or a non-targeting control shRNA (shCtr).

    Techniques: Expressing, Quantitative RT-PCR, shRNA, Construct, Western Blot, One-tailed Test, Staining, Injection, Two Tailed Test, MANN-WHITNEY

    Metabolic changes in H295R cells related to ERRα expression levels. The metabolic profiles of H295R wild type (WT), shCTR, shERRα−/− and ERRα+/+ cells were assessed by Seahorse XFe96 Analyzer. ( a , b ) ATP Rate Assay was evaluated as indicated in “Materials and Methods”. Graphs represent the mean ± SD of three independent experiments of Total ATP Production Rate (pmol/min) ( a ) and ATP production (%) ( b ) deriving from glycolysis and oxidative phosphorylation after the sequential addition of specific inhibitors; (* p < 0.05 vs. WT). ( c – e ) Mitochondrial Stress Analysis was performed as indicated in “Materials and Methods”. Graphs represent the mean ± SD of three independent experiments of real-time oxygen consumption (OCR) rate (pmol/min/cells); (* p < 0.05 vs. shCTR). Mitochondrial Respiration ( c ), Basal Respiration ( d ), Maximal Respiration ( e ) were measured from OCR after the addition of specific inhibitors. ( f – h ) Glycolytic Stress Analysis was performed as indicated in “Materials and Methods”. Graph represents the mean ± SD of three independent experiments of Real-time extracellular acidification (ECAR) rate (mpH/min/cells); (* p < 0.05 vs. shCTR). Glycolitic function ( f ), Glycolysis ( g ) and Glycolytic Capacity ( h ) were measured from ECAR after the addition of specific inhibitors.

    Journal: Cancers

    Article Title: Estrogen Related Receptor Alpha (ERRα) a Bridge between Metabolism and Adrenocortical Cancer Progression

    doi: 10.3390/cancers14163885

    Figure Lengend Snippet: Metabolic changes in H295R cells related to ERRα expression levels. The metabolic profiles of H295R wild type (WT), shCTR, shERRα−/− and ERRα+/+ cells were assessed by Seahorse XFe96 Analyzer. ( a , b ) ATP Rate Assay was evaluated as indicated in “Materials and Methods”. Graphs represent the mean ± SD of three independent experiments of Total ATP Production Rate (pmol/min) ( a ) and ATP production (%) ( b ) deriving from glycolysis and oxidative phosphorylation after the sequential addition of specific inhibitors; (* p < 0.05 vs. WT). ( c – e ) Mitochondrial Stress Analysis was performed as indicated in “Materials and Methods”. Graphs represent the mean ± SD of three independent experiments of real-time oxygen consumption (OCR) rate (pmol/min/cells); (* p < 0.05 vs. shCTR). Mitochondrial Respiration ( c ), Basal Respiration ( d ), Maximal Respiration ( e ) were measured from OCR after the addition of specific inhibitors. ( f – h ) Glycolytic Stress Analysis was performed as indicated in “Materials and Methods”. Graph represents the mean ± SD of three independent experiments of Real-time extracellular acidification (ECAR) rate (mpH/min/cells); (* p < 0.05 vs. shCTR). Glycolitic function ( f ), Glycolysis ( g ) and Glycolytic Capacity ( h ) were measured from ECAR after the addition of specific inhibitors.

    Article Snippet: After 48 h, cells were transfected with DNA plasmids: a plasmid encoding a scrambled short hairpin RNAs (shRNA) sequence (shCTR) (Santa Cruz, sc108060, Dallas, TX, USA), a plasmid expressing a shRNA to inhibit ERRα gene (shERRα−/−) (Santa Cruz, sc44706-sh), according to the manufacturer’s protocol (Santa Cruz Biotecnology, https://www.scbt.com/it/resources/protocols/shrna-plasmid-dna-mediated-inhibition-of-gene-expression (accessed on 7 January 2020)), or ERRα cDNA expression plasmid(ERRα+/+) (ADGENE, #10975), according to X-tremeGENETM HP DNA Transfection Reagent Protocol (Sigma).

    Techniques: Expressing, Phospho-proteomics

    ERRα modulates H295R cell motility and Vimentin expression. ( a , b ) H295R (WT), H295R clones, knock in (ERRα+/+) or knock out (shERRα−/−) for ERRα gene, and H295R cell stably transfected with control plasmid (shCTR) were used in Wound Healing ( a ) and Boyden Chamber ( b ) assays as reported in “Materials and Methods”. Images are from a representative experiment. ( c , d ) H295R cells were treated with vehicle (0) or XCT790 (1, 5, 10 μM) for 18 h and Wound Healing ( c ) and Boyden Chamber ( d ) assays were performed as reported in “Materials and Methods”. Images are from a representative experiment. ( c ) The wounds were observed under an inverted microscope immediately (0 h) and 18 h after the scratch (100× magnification). ( b , d ) Migrated cells were photographed under an inverted microscope and counted (see Material and Methods), 20× magnification. Graphs represent the mean ± SD of three independent experiments. The number of untreated cells (0) was set as 100% (* p < 0.05 vs. 0). ( e ) Total proteins from H295R clones (shCTR, shERRα−/−, ERRα+/+) were analyzed by western Blotting (WB) using antibodies against ERRα and Vimentin. GAPDH was used as a loading control. Blots are representative of three independent experiments with similar results. ( f ) H295R were transfected for 48 h with pcDNA3.1 non containing (EV) or containing ERRα coding sequence (pcDNA3.1-ERRα). After transfection cells were left untreated (−) or treated (+) for 24 h with XCT790 (10 μM). Total proteins were analyzed by WB using antibodies against ERRα and Vimentin. GAPDH was used as a loading control. ( g ) Cells were untreated (0) or treated with XCT790 (1, 5, 10 μM) for 24 h. Total proteins were analyzed by WB using antibodies against ERRα and Vimentin. GAPDH was used as a loading control. Original image of western blot can be found at .

    Journal: Cancers

    Article Title: Estrogen Related Receptor Alpha (ERRα) a Bridge between Metabolism and Adrenocortical Cancer Progression

    doi: 10.3390/cancers14163885

    Figure Lengend Snippet: ERRα modulates H295R cell motility and Vimentin expression. ( a , b ) H295R (WT), H295R clones, knock in (ERRα+/+) or knock out (shERRα−/−) for ERRα gene, and H295R cell stably transfected with control plasmid (shCTR) were used in Wound Healing ( a ) and Boyden Chamber ( b ) assays as reported in “Materials and Methods”. Images are from a representative experiment. ( c , d ) H295R cells were treated with vehicle (0) or XCT790 (1, 5, 10 μM) for 18 h and Wound Healing ( c ) and Boyden Chamber ( d ) assays were performed as reported in “Materials and Methods”. Images are from a representative experiment. ( c ) The wounds were observed under an inverted microscope immediately (0 h) and 18 h after the scratch (100× magnification). ( b , d ) Migrated cells were photographed under an inverted microscope and counted (see Material and Methods), 20× magnification. Graphs represent the mean ± SD of three independent experiments. The number of untreated cells (0) was set as 100% (* p < 0.05 vs. 0). ( e ) Total proteins from H295R clones (shCTR, shERRα−/−, ERRα+/+) were analyzed by western Blotting (WB) using antibodies against ERRα and Vimentin. GAPDH was used as a loading control. Blots are representative of three independent experiments with similar results. ( f ) H295R were transfected for 48 h with pcDNA3.1 non containing (EV) or containing ERRα coding sequence (pcDNA3.1-ERRα). After transfection cells were left untreated (−) or treated (+) for 24 h with XCT790 (10 μM). Total proteins were analyzed by WB using antibodies against ERRα and Vimentin. GAPDH was used as a loading control. ( g ) Cells were untreated (0) or treated with XCT790 (1, 5, 10 μM) for 24 h. Total proteins were analyzed by WB using antibodies against ERRα and Vimentin. GAPDH was used as a loading control. Original image of western blot can be found at .

    Article Snippet: After 48 h, cells were transfected with DNA plasmids: a plasmid encoding a scrambled short hairpin RNAs (shRNA) sequence (shCTR) (Santa Cruz, sc108060, Dallas, TX, USA), a plasmid expressing a shRNA to inhibit ERRα gene (shERRα−/−) (Santa Cruz, sc44706-sh), according to the manufacturer’s protocol (Santa Cruz Biotecnology, https://www.scbt.com/it/resources/protocols/shrna-plasmid-dna-mediated-inhibition-of-gene-expression (accessed on 7 January 2020)), or ERRα cDNA expression plasmid(ERRα+/+) (ADGENE, #10975), according to X-tremeGENETM HP DNA Transfection Reagent Protocol (Sigma).

    Techniques: Expressing, Clone Assay, Knock-In, Knock-Out, Stable Transfection, Transfection, Control, Plasmid Preparation, Inverted Microscopy, Western Blot, Sequencing

    ERRα promotes H295R spheroids formation. ( a ) H295R were transfected for 48 h with pcDNA3.1 non containing (EV) or containing ERRα coding sequence (pcDNA3.1-ERRα) and then grown as 3D spheroids for 5 days. Spheroids were counted under an inverted microscope and results were expressed as fold change over control (EV) ± SD (TSFE, tumor spheroids formation efficiency); (* p < 0.05 vs. EV). Insert confirms ERRα overexpression. ( b ) H295R cells were left untreated (0) or treated with XCT790 (1, 5, 10 μM) for 24 h and TSFE was evaluated 5 days later (* p < 0.05 vs. 0). Images below graph are from a representative experiment (20× magnification). ( c ) Wild type H295R (WT) and H295R clones (shCTR, shERRα−/−, ERRα+/+) were used to evaluate 3D spheroids formation. TSFE was evaluated 5 days later (* p < 0.05 vs. WT). Images below graph are from a representative experiment (20× magnification). ( d ) H295R spheroids (H295R Sph-5) were allowed to grow for 5 days and then trypsinized and reseeded weekly in spheroid media for 5 weeks. Boyden Chamber Assay was performed as reported in the “Materials and Methods”. Migrated cells were randomly photographed and counted with ImageJ software (* p < 0.05 vs. WT). ( e ) H295R (WT) cells and H295R grown as spheroids for 5 weeks (H295R Sph-5), were analyzed by WB using antibody against Vimentin. GAPDH was used as a loading control. Blots are representative of three independent experiments with similar results. Original image of western blot can be found at .

    Journal: Cancers

    Article Title: Estrogen Related Receptor Alpha (ERRα) a Bridge between Metabolism and Adrenocortical Cancer Progression

    doi: 10.3390/cancers14163885

    Figure Lengend Snippet: ERRα promotes H295R spheroids formation. ( a ) H295R were transfected for 48 h with pcDNA3.1 non containing (EV) or containing ERRα coding sequence (pcDNA3.1-ERRα) and then grown as 3D spheroids for 5 days. Spheroids were counted under an inverted microscope and results were expressed as fold change over control (EV) ± SD (TSFE, tumor spheroids formation efficiency); (* p < 0.05 vs. EV). Insert confirms ERRα overexpression. ( b ) H295R cells were left untreated (0) or treated with XCT790 (1, 5, 10 μM) for 24 h and TSFE was evaluated 5 days later (* p < 0.05 vs. 0). Images below graph are from a representative experiment (20× magnification). ( c ) Wild type H295R (WT) and H295R clones (shCTR, shERRα−/−, ERRα+/+) were used to evaluate 3D spheroids formation. TSFE was evaluated 5 days later (* p < 0.05 vs. WT). Images below graph are from a representative experiment (20× magnification). ( d ) H295R spheroids (H295R Sph-5) were allowed to grow for 5 days and then trypsinized and reseeded weekly in spheroid media for 5 weeks. Boyden Chamber Assay was performed as reported in the “Materials and Methods”. Migrated cells were randomly photographed and counted with ImageJ software (* p < 0.05 vs. WT). ( e ) H295R (WT) cells and H295R grown as spheroids for 5 weeks (H295R Sph-5), were analyzed by WB using antibody against Vimentin. GAPDH was used as a loading control. Blots are representative of three independent experiments with similar results. Original image of western blot can be found at .

    Article Snippet: After 48 h, cells were transfected with DNA plasmids: a plasmid encoding a scrambled short hairpin RNAs (shRNA) sequence (shCTR) (Santa Cruz, sc108060, Dallas, TX, USA), a plasmid expressing a shRNA to inhibit ERRα gene (shERRα−/−) (Santa Cruz, sc44706-sh), according to the manufacturer’s protocol (Santa Cruz Biotecnology, https://www.scbt.com/it/resources/protocols/shrna-plasmid-dna-mediated-inhibition-of-gene-expression (accessed on 7 January 2020)), or ERRα cDNA expression plasmid(ERRα+/+) (ADGENE, #10975), according to X-tremeGENETM HP DNA Transfection Reagent Protocol (Sigma).

    Techniques: Transfection, Sequencing, Inverted Microscopy, Control, Over Expression, Clone Assay, Boyden Chamber Assay, Software, Western Blot

    ERRα expression levels and cholesterol influence H295R cell migration. ( a ) H295R clones (shCTR, ERRα+/+, shERRα−/−) were maintained in 5% FBS or 5% LpFS containing medium. Cells were used in Wound Healing ( a ) and Boyden Chamber ( b ) assays performed as reported in “Materials and Methods”. ( a ) Images are from a representative experiment (100× magnification). ( b ) Migrated cells were photographed under an inverted microscope (20× magnification) and counted with ImageJ software. Graphs represent the mean ± SD of three independent experiments (* p < 0.05 vs. FBS).

    Journal: Cancers

    Article Title: Estrogen Related Receptor Alpha (ERRα) a Bridge between Metabolism and Adrenocortical Cancer Progression

    doi: 10.3390/cancers14163885

    Figure Lengend Snippet: ERRα expression levels and cholesterol influence H295R cell migration. ( a ) H295R clones (shCTR, ERRα+/+, shERRα−/−) were maintained in 5% FBS or 5% LpFS containing medium. Cells were used in Wound Healing ( a ) and Boyden Chamber ( b ) assays performed as reported in “Materials and Methods”. ( a ) Images are from a representative experiment (100× magnification). ( b ) Migrated cells were photographed under an inverted microscope (20× magnification) and counted with ImageJ software. Graphs represent the mean ± SD of three independent experiments (* p < 0.05 vs. FBS).

    Article Snippet: After 48 h, cells were transfected with DNA plasmids: a plasmid encoding a scrambled short hairpin RNAs (shRNA) sequence (shCTR) (Santa Cruz, sc108060, Dallas, TX, USA), a plasmid expressing a shRNA to inhibit ERRα gene (shERRα−/−) (Santa Cruz, sc44706-sh), according to the manufacturer’s protocol (Santa Cruz Biotecnology, https://www.scbt.com/it/resources/protocols/shrna-plasmid-dna-mediated-inhibition-of-gene-expression (accessed on 7 January 2020)), or ERRα cDNA expression plasmid(ERRα+/+) (ADGENE, #10975), according to X-tremeGENETM HP DNA Transfection Reagent Protocol (Sigma).

    Techniques: Expressing, Migration, Clone Assay, Inverted Microscopy, Software

    PHGDH knockdown potentiates bortezomib and proteasome-resistant cell lines are sensitive to PHGDH inhibition. a The knockdown of PHGDH using shRNA was confirmed via WB. b CTG was used to highlight the dependence of the shPHGDH cells on extracellular serine. The sensitivity to drugs was tested by CTG. c , d INA6 KD cells were treated overnight with carfilzomib and bortezomib, respectively. e , f INA6-res and AMO1-res cell lines, respectively, were treated with the indicated doses of NCT-503 overnight. All the presented graphs and calculated IC50s represent three independent experiments with minimum two replicates. Error bars are ± SEM and * P ≤ 0.05 , ** P ≤ 0.01, *** P ≤ 0.001

    Journal: Experimental Hematology & Oncology

    Article Title: Targeting phosphoglycerate dehydrogenase in multiple myeloma

    doi: 10.1186/s40164-020-00196-w

    Figure Lengend Snippet: PHGDH knockdown potentiates bortezomib and proteasome-resistant cell lines are sensitive to PHGDH inhibition. a The knockdown of PHGDH using shRNA was confirmed via WB. b CTG was used to highlight the dependence of the shPHGDH cells on extracellular serine. The sensitivity to drugs was tested by CTG. c , d INA6 KD cells were treated overnight with carfilzomib and bortezomib, respectively. e , f INA6-res and AMO1-res cell lines, respectively, were treated with the indicated doses of NCT-503 overnight. All the presented graphs and calculated IC50s represent three independent experiments with minimum two replicates. Error bars are ± SEM and * P ≤ 0.05 , ** P ≤ 0.01, *** P ≤ 0.001

    Article Snippet: Following the manufacturer’s protocol, INA6 knockdown cells (INA6-KD) were transduced with lentiviral particles containing either non-target control shRNA (shCTR) or shRNA targeting PHGDH (shPHGDH) (Santa Cruz Biotechnology, Dallas, TX, USA; sc-108080 and sc-105011-V).

    Techniques: Knockdown, Inhibition, shRNA